Spots Global Cancer Trial Database for taxotere (docetaxel)
Every month we try and update this database with for taxotere (docetaxel) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer | NCT00675597 | Lung Cancer | Bevacizumab (Av... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Safety Study of Combined Systemic and Intraperitoneal Chemotherapy to Treat Stomach Cancer | NCT01525771 | Stage IV Gastri... | Docetaxel | 18 Years - | Asan Medical Center | |
| Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN) | NCT01443078 | Lung Cancer | pemetrexed cisplatin Carboplatin Gemcitabine Hyd... Vinorelbine Tar... Docetaxel | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors | NCT01172028 | Breast Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Lung Cancer Ovarian Cancer Prostate Cancer | Taxotere (Docet... Alimta (Pemetre... | 18 Years - | University of Arizona | |
| Safety Study of Combined Systemic and Intraperitoneal Chemotherapy to Treat Stomach Cancer | NCT01525771 | Stage IV Gastri... | Docetaxel | 18 Years - | Asan Medical Center | |
| Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma | NCT00737438 | Esophageal Canc... Gastric Cancer | epirubicin, cis... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors | NCT01172028 | Breast Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Lung Cancer Ovarian Cancer Prostate Cancer | Taxotere (Docet... Alimta (Pemetre... | 18 Years - | University of Arizona | |
| RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer | NCT00935961 | HEAD & NECK Can... | RAD001 + doceta... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes | NCT00887809 | Sarcoma Leiomyosarcoma Malignant Fibro... Histiocytoma Angiosarcoma | gemcitabine docetaxel bevacizumab | 18 Years - 75 Years | Memorial Sloan Kettering Cancer Center | |
| Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer | NCT00031187 | Prostatic Neopl... | SGN-15 (cBR96-d... Taxotere (docet... | 18 Years - | Seagen Inc. | |
| A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer | NCT06296706 | Gastric Cancer | Docetaxel for i... Taxotere (docet... | 18 Years - 75 Years | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | |
| Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer | NCT00031187 | Prostatic Neopl... | SGN-15 (cBR96-d... Taxotere (docet... | 18 Years - | Seagen Inc. | |
| Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma | NCT00737438 | Esophageal Canc... Gastric Cancer | epirubicin, cis... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer | NCT00935961 | HEAD & NECK Can... | RAD001 + doceta... | 18 Years - | Memorial Sloan Kettering Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
